Nu Skin Enterprises (NUS) Financials

$7.26 -0.06 (-0.82%)

Closing price 05/23/2025 03:59 PM Eastern

Extended Trading

$7.20 -0.06 (-0.90%)

As of 05/23/2025 07:12 PM Eastern

Annual Income Statements for Nu Skin Enterprises

This table shows Nu Skin Enterprises' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Income / (Loss) Attributable to Common Shareholders	-147	8.60	105
Consolidated Net Income / (Loss)	-147	8.60	105
Net Income / (Loss) Continuing Operations	-147	8.60	105
Total Pre-Tax Income	-175	27	89
Total Operating Income	-152	48	111
Total Gross Profit	1,182	1,357	1,595
Total Revenue	1,732	1,969	2,226
Operating Revenue	1,732	1,969	2,226
Total Cost of Revenue	550	612	631
Operating Cost of Revenue	550	612	631
Total Operating Expenses	1,333	1,309	1,484
Selling, General & Admin Expense	1,131	1,289	1,435
Restructuring Charge	202	20	48
Total Other Income / (Expense), net	-23	-22	-22
Interest Expense	26	26	13
Other Income / (Expense), net	2.94	3.87	-8.38
Income Tax Expense	-28	18	-16
Basic Earnings per Share	($2.95)	$0.17	$2.10
Weighted Average Basic Shares Outstanding	49.66M	49.71M	50.00M
Diluted Earnings per Share	($2.95)	$0.17	$2.07
Weighted Average Diluted Shares Outstanding	49.66M	49.86M	50.53M
Weighted Average Basic & Diluted Shares Outstanding	49.72M	49.42M	49.46M

This table shows Nu Skin Enterprises' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-36	8.30	-118	-0.53	7.28	-37	27	11	57	-25
Consolidated Net Income / (Loss)	-36	8.30	-118	-0.53	7.28	-37	27	11	57	-25
Net Income / (Loss) Continuing Operations	-36	8.30	-118	-0.53	7.28	-37	27	11	57	-25
Total Pre-Tax Income	-58	13	-132	1.10	9.33	-34	37	15	24	-29
Total Operating Income	-53	18	-126	8.82	16	-26	43	16	27	-20
Total Gross Profit	279	301	307	294	352	292	365	348	375	364
Total Revenue	446	430	439	417	489	499	500	481	522	538
Operating Revenue	446	430	439	417	489	499	500	481	522	538
Total Cost of Revenue	166	129	132	123	136	207	136	134	148	174
Operating Cost of Revenue	166	129	132	123	136	207	136	134	148	174
Total Operating Expenses	332	283	433	285	336	319	322	332	347	385
Selling, General & Admin Expense	286	283	283	278	326	319	322	322	329	354
Restructuring Charge	46	0.00	149	7.13	10	0.00	0.00	9.79	18	30
Total Other Income / (Expense), net	-4.72	-4.93	-6.09	-7.72	-6.74	-8.09	-5.39	-1.48	-3.10	-8.68
Interest Expense	5.86	6.50	6.72	7.33	7.37	7.54	5.77	4.89	-	-
Other Income / (Expense), net	1.14	1.57	0.63	-0.40	0.63	-0.55	0.38	3.41	10	-8.68
Income Tax Expense	-22	5.00	-13	1.63	2.05	2.50	10	3.21	-33	-3.57
Basic Earnings per Share	($0.73)	$0.17	($2.38)	($0.01)	$0.14	($0.74)	$0.54	$0.23	$1.16	($0.51)
Weighted Average Basic Shares Outstanding	49.66M	49.71M	49.69M	49.54M	49.71M	49.86M	49.93M	49.64M	50.00M	50.20M
Diluted Earnings per Share	($0.73)	$0.17	($2.38)	($0.01)	$0.14	($0.74)	$0.54	$0.23	$1.15	($0.51)
Weighted Average Diluted Shares Outstanding	49.66M	49.73M	49.69M	49.54M	49.86M	49.86M	50.16M	50.06M	50.53M	50.20M
Weighted Average Basic & Diluted Shares Outstanding	49.72M	49.71M	49.70M	49.67M	49.42M	49.41M	49.96M	49.91M	49.46M	49.42M

This table details how cash moves in and out of Nu Skin Enterprises' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Change in Cash & Equivalents	-69	-8.67	-75
Net Cash From Operating Activities	112	119	108
Net Cash From Continuing Operating Activities	112	119	108
Net Income / (Loss) Continuing Operations	-147	8.60	105
Consolidated Net Income / (Loss)	-147	8.60	105
Depreciation Expense	70	71	73
Non-Cash Adjustments To Reconcile Net Income	272	139	118
Changes in Operating Assets and Liabilities, net	-84	-100	-188
Net Cash From Investing Activities	-38	-135	-67
Net Cash From Continuing Investing Activities	-38	-135	-67
Purchase of Property, Plant & Equipment	-42	-58	-59
Acquisitions	0.00	-77	0.00
Purchase of Investments	-15	-17	-14
Sale and/or Maturity of Investments	18	18	5.93
Net Cash From Financing Activities	-133	11	-100
Net Cash From Continuing Financing Activities	-133	11	-100
Repayment of Debt	-128	-13	-438
Repurchase of Common Equity	0.00	-13	-70
Payment of Dividends	-12	-78	-77
Issuance of Debt	15	110	460
Other Financing Activities, net	-8.36	4.56	25
Effect of Exchange Rate Changes	-9.78	-3.54	-16

This table details how cash moves in and out of Nu Skin Enterprises' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-41	3.50	12	-44	23	-2.24	5.61	-35	-29	-70
Net Cash From Operating Activities	26	31	51	3.32	54	51	36	-22	26	28
Net Cash From Continuing Operating Activities	26	31	51	3.32	54	51	36	-22	26	28
Net Income / (Loss) Continuing Operations	-36	8.30	-118	-0.53	7.28	-37	27	11	57	-25
Consolidated Net Income / (Loss)	-36	8.30	-118	-0.53	7.28	-37	27	11	57	-25
Depreciation Expense	16	17	18	18	19	18	17	17	19	18
Non-Cash Adjustments To Reconcile Net Income	83	14	160	16	17	83	26	14	20	65
Changes in Operating Assets and Liabilities, net	-38	-7.96	-7.66	-31	11	-13	-34	-64	-71	-29
Net Cash From Investing Activities	-14	-6.55	-8.53	-9.26	-15	-12	-93	-15	-13	-25
Net Cash From Continuing Investing Activities	-14	-6.55	-8.53	-9.26	-15	-12	-93	-15	-13	-25
Purchase of Property, Plant & Equipment	-13	-8.60	-8.12	-12	-20	-12	-15	-11	-14	-25
Purchase of Investments	-1.04	-5.15	-8.57	0.00	-	-	-8.69	-8.20	-	-
Net Cash From Financing Activities	-44	-29	-29	-32	-20	-38	68	1.38	-51	-61
Net Cash From Continuing Financing Activities	-44	-29	-29	-32	-20	-38	68	1.38	-51	-61
Repayment of Debt	-43	-40	-25	-20	-3.20	-3.45	-4.05	-2.50	-23	-2.50
Payment of Dividends	-2.98	-2.98	-2.98	-2.98	-19	-19	-19	-19	-19	-19
Other Financing Activities, net	2.24	-0.80	-0.84	-8.98	2.20	-2.42	1.51	3.27	0.74	0.72
Effect of Exchange Rate Changes	-9.41	7.39	-	-	4.24	-2.99	-	-	9.24	-12

This table presents Nu Skin Enterprises' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Total Assets	1,469	1,809	1,821
Total Current Assets	539	702	760
Cash & Equivalents	187	256	265
Short-Term Investments	11	12	14
Accounts Receivable	51	59	47
Inventories, net	190	280	346
Prepaid Expenses	73	81	88
Other Current Nonoperating Assets	27	14	-
Plant, Property, & Equipment, net	380	433	445
Total Noncurrent Assets	551	674	616
Goodwill	84	218	206
Intangible Assets	74	95	67
Other Noncurrent Operating Assets	371	338	343
Other Noncurrent Nonoperating Assets	22	23	-
Total Liabilities & Shareholders' Equity	1,469	1,809	1,821
Total Liabilities	817	987	924
Total Current Liabilities	297	329	359
Short-Term Debt	30	25	25
Accounts Payable	35	43	54
Accrued Expenses	218	254	280
Other Current Nonoperating Liabilities	14	7.06	-
Total Noncurrent Liabilities	521	658	564
Long-Term Debt	364	478	377
Other Noncurrent Operating Liabilities	156	178	187
Other Noncurrent Nonoperating Liabilities	1.33	2.16	-
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	651	822	897
Total Preferred & Common Equity	651	822	897
Total Common Equity	651	822	897
Common Stock	628	622	613
Retained Earnings	1,712	1,870	1,939
Treasury Stock	-1,564	-1,570	-1,569
Accumulated Other Comprehensive Income / (Loss)	-125	-100	-87

This table presents Nu Skin Enterprises' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	1,583	1,586	1,742	1,793	1,894	1,825	1,763
Total Current Assets	653	654	647	701	793	774	778
Cash & Equivalents	228	224	213	233	236	230	294
Short-Term Investments	10	8.67	8.67	17	17	17	14
Accounts Receivable	69	72	67	77	67	60	48
Inventories, net	248	244	265	291	372	367	327
Prepaid Expenses	99	106	94	83	101	100	94
Plant, Property, & Equipment, net	411	412	423	429	430	438	433
Total Noncurrent Assets	519	520	672	663	671	613	552
Goodwill	100	100	231	229	229	206	206
Intangible Assets	85	88	102	109	113	65	69
Other Noncurrent Operating Assets	334	331	339	325	329	342	277
Total Liabilities & Shareholders' Equity	1,583	1,586	1,742	1,793	1,894	1,825	1,763
Total Liabilities	876	900	932	971	998	932	921
Total Current Liabilities	339	309	309	434	445	373	366
Short-Term Debt	60	30	30	140	140	48	43
Accounts Payable	33	36	32	49	50	49	42
Accrued Expenses	247	242	247	245	256	276	281
Total Noncurrent Liabilities	537	591	622	537	553	559	556
Long-Term Debt	373	428	453	363	368	373	382
Other Noncurrent Operating Liabilities	163	163	169	174	186	186	173
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	707	686	810	822	895	893	842
Total Preferred & Common Equity	707	686	810	822	895	893	842
Total Common Equity	707	686	810	822	895	893	842
Common Stock	625	622	619	619	616	612	610
Retained Earnings	1,751	1,746	1,867	1,882	1,939	1,931	1,901
Treasury Stock	-1,564	-1,564	-1,565	-1,571	-1,558	-1,559	-1,560
Accumulated Other Comprehensive Income / (Loss)	-105	-117	-111	-109	-101	-91	-109

This table displays calculated financial ratios and metrics derived from Nu Skin Enterprises' official financial filings.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Growth Metrics	-	-	-
Revenue Growth	-12.04%	-11.53%	-17.44%
EBITDA Growth	-164.06%	-29.67%	-43.34%
EBIT Growth	-385.09%	-49.12%	-55.92%
NOPAT Growth	-779.78%	-88.04%	-11.94%
Net Income Growth	-1,805.57%	-91.80%	-28.85%
EPS Growth	-1,835.29%	-91.79%	-27.62%
Operating Cash Flow Growth	-5.81%	9.79%	-23.68%
Free Cash Flow Firm Growth	1,384.93%	-82.96%	120.25%
Invested Capital Growth	-21.01%	0.80%	9.31%
Revenue Q/Q Growth	-2.43%	-1.68%	-6.36%
EBITDA Q/Q Growth	-134.46%	-5.85%	12.56%
EBIT Q/Q Growth	-40.80%	-12.81%	23.38%
NOPAT Q/Q Growth	-83.87%	-81.40%	172.72%
Net Income Q/Q Growth	-42.04%	-85.31%	173.34%
EPS Q/Q Growth	-41.83%	-85.59%	176.00%
Operating Cash Flow Q/Q Growth	-20.25%	31.83%	-43.73%
Free Cash Flow Firm Q/Q Growth	-4.10%	122.89%	-61.33%
Invested Capital Q/Q Growth	-9.90%	-4.25%	6.52%
Profitability Metrics	-	-	-
Gross Margin	68.23%	68.93%	71.65%
EBITDA Margin	-4.55%	6.25%	7.86%
Operating Margin	-8.75%	2.45%	4.98%
EBIT Margin	-8.58%	2.65%	4.60%
Profit (Net Income) Margin	-8.46%	0.44%	4.71%
Tax Burden Percent	83.74%	32.34%	117.77%
Interest Burden Percent	117.77%	50.98%	86.83%
Effective Tax Rate	0.00%	67.66%	-17.77%
Return on Invested Capital (ROIC)	-11.52%	1.52%	13.35%
ROIC Less NNEP Spread (ROIC-NNEP)	-33.45%	-2.71%	-22.08%
Return on Net Nonoperating Assets (RNNOA)	-8.38%	-0.52%	-1.77%
Return on Equity (ROE)	-19.90%	1.00%	11.58%
Cash Return on Invested Capital (CROIC)	11.96%	0.72%	4.45%
Operating Return on Assets (OROA)	-9.07%	2.87%	5.50%
Return on Assets (ROA)	-8.95%	0.47%	5.62%
Return on Common Equity (ROCE)	-19.90%	1.00%	11.58%
Return on Equity Simple (ROE_SIMPLE)	-22.50%	1.05%	11.68%
Net Operating Profit after Tax (NOPAT)	-106	16	131
NOPAT Margin	-6.13%	0.79%	5.87%
Net Nonoperating Expense Percent (NNEP)	21.93%	4.23%	35.43%
Return On Investment Capital (ROIC_SIMPLE)	-10.15%	1.18%	10.04%
Cost of Revenue to Revenue	31.77%	31.07%	28.35%
SG&A Expenses to Revenue	65.30%	65.47%	64.49%
R&D to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	76.98%	66.48%	66.67%
Earnings before Interest and Taxes (EBIT)	-149	52	102
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-79	123	175
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	0.53	1.14	2.13
Price to Tangible Book Value (P/TBV)	0.69	1.84	3.07
Price to Revenue (P/Rev)	0.20	0.48	0.86
Price to Earnings (P/E)	0.00	109.01	18.28
Dividend Yield	3.48%	8.23%	3.97%
Earnings Yield	0.00%	0.92%	5.47%
Enterprise Value to Invested Capital (EV/IC)	0.66	1.14	2.00
Enterprise Value to Revenue (EV/Rev)	0.31	0.60	0.92
Enterprise Value to EBITDA (EV/EBITDA)	0.00	9.53	11.66
Enterprise Value to EBIT (EV/EBIT)	0.00	22.48	19.90
Enterprise Value to NOPAT (EV/NOPAT)	0.00	75.10	15.62
Enterprise Value to Operating Cash Flow (EV/OCF)	4.82	9.88	18.87
Enterprise Value to Free Cash Flow (EV/FCFF)	4.89	158.02	46.85
Leverage & Solvency	-	-	-
Debt to Equity	0.60	0.61	0.45
Long-Term Debt to Equity	0.56	0.58	0.42
Financial Leverage	0.25	0.19	0.08
Leverage Ratio	2.22	2.11	2.06
Compound Leverage Factor	2.62	1.08	1.79
Debt to Total Capital	37.66%	37.97%	30.96%
Short-Term Debt to Total Capital	2.87%	1.89%	1.92%
Long-Term Debt to Total Capital	34.79%	36.08%	29.04%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	62.34%	62.03%	69.04%
Debt to EBITDA	-4.99	4.09	2.30
Net Debt to EBITDA	-2.48	1.91	0.71
Long-Term Debt to EBITDA	-4.61	3.88	2.16
Debt to NOPAT	-3.71	32.23	3.08
Net Debt to NOPAT	-1.84	15.07	0.95
Long-Term Debt to NOPAT	-3.43	30.63	2.89
Altman Z-Score	2.93	3.45	4.41
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	1.82	2.13	2.12
Quick Ratio	0.84	0.99	0.91
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	110	7.42	44
Operating Cash Flow to CapEx	268.72%	202.84%	182.98%
Free Cash Flow to Firm to Interest Expense	4.17	0.29	3.23
Operating Cash Flow to Interest Expense	4.23	4.64	8.01
Operating Cash Flow Less CapEx to Interest Expense	2.66	2.35	3.63
Efficiency Ratios	-	-	-
Asset Turnover	1.06	1.09	1.19
Accounts Receivable Turnover	31.64	37.13	50.21
Inventory Turnover	2.34	1.95	1.69
Fixed Asset Turnover	4.26	4.49	4.95
Accounts Payable Turnover	14.11	12.61	12.14
Days Sales Outstanding (DSO)	11.54	9.83	7.27
Days Inventory Outstanding (DIO)	155.96	186.77	215.82
Days Payable Outstanding (DPO)	25.87	28.96	30.07
Cash Conversion Cycle (CCC)	141.63	167.64	193.02
Capital & Investment Metrics	-	-	-
Invested Capital	813	1,029	1,021
Invested Capital Turnover	1.88	1.92	2.28
Increase / (Decrease) in Invested Capital	-216	8.19	87
Enterprise Value (EV)	538	1,172	2,039
Market Capitalization	343	937	1,915
Book Value per Share	$13.10	$16.64	$18.16
Tangible Book Value per Share	$9.93	$10.29	$12.63
Total Capital	1,045	1,325	1,300
Total Debt	394	503	402
Total Long-Term Debt	364	478	377
Net Debt	196	235	124
Capital Expenditures (CapEx)	42	58	59
Debt-free, Cash-free Net Working Capital (DFCFNWC)	74	130	147
Debt-free Net Working Capital (DFNWC)	272	398	426
Net Working Capital (NWC)	242	373	401
Net Nonoperating Expense (NNE)	40	7.01	26
Net Nonoperating Obligations (NNO)	162	207	124
Total Depreciation and Amortization (D&A)	70	71	73
Debt-free, Cash-free Net Working Capital to Revenue	4.27%	6.61%	6.61%
Debt-free Net Working Capital to Revenue	15.70%	20.21%	19.12%
Net Working Capital to Revenue	13.97%	18.94%	18.00%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($2.95)	$0.17	$2.10
Adjusted Weighted Average Basic Shares Outstanding	49.66M	49.71M	50.00M
Adjusted Diluted Earnings per Share	($2.95)	$0.17	$2.07
Adjusted Weighted Average Diluted Shares Outstanding	49.66M	49.86M	50.53M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	49.72M	49.42M	49.46M
Normalized Net Operating Profit after Tax (NOPAT)	36	48	112
Normalized NOPAT Margin	2.05%	2.42%	5.01%
Pre Tax Income Margin	-10.11%	1.35%	4.00%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	-5.63	2.04	7.59
NOPAT to Interest Expense	-4.02	0.61	9.67
EBIT Less CapEx to Interest Expense	-7.20	-0.25	3.22
NOPAT Less CapEx to Interest Expense	-5.59	-1.68	5.30
Payout Ratios	-	-	-
Dividend Payout Ratio	-8.14%	903.11%	73.50%
Augmented Payout Ratio	-8.14%	1,054.49%	140.35%

This table displays calculated financial ratios and metrics derived from Nu Skin Enterprises' official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-8.82%	-13.76%	-12.23%	-13.33%	-6.45%	-7.26%	-10.77%	-20.41%	-22.44%	-16.12%
EBITDA Growth	-200.59%	525.48%	-278.74%	-26.32%	-37.47%	19.17%	-2.40%	-46.24%	52.91%	-112.25%
EBIT Growth	-411.08%	173.55%	-391.33%	-56.74%	-55.89%	7.07%	-0.01%	-61.58%	105.31%	-142.49%
NOPAT Growth	-396.31%	161.67%	-385.36%	-134.09%	-80.56%	-29.98%	-25.12%	-68.55%	734.01%	-129.77%
Net Income Growth	-595.81%	122.47%	-539.75%	-104.69%	-87.27%	-45.55%	-21.45%	-70.62%	719.81%	-151.06%
EPS Growth	-621.43%	122.97%	-540.74%	-104.35%	-87.83%	-45.10%	-19.40%	-69.74%	776.47%	-152.58%
Operating Cash Flow Growth	-52.40%	-38.40%	44.16%	115.03%	112.21%	79.41%	-23.70%	-392.76%	-76.69%	-5.87%
Free Cash Flow Firm Growth	4,018.64%	236.47%	213.29%	85.20%	119.32%	-367.00%	-491.31%	-39.24%	83.77%	127.50%
Invested Capital Growth	-21.01%	-16.05%	-20.79%	0.55%	0.80%	12.13%	16.66%	8.19%	9.31%	-6.32%
Revenue Q/Q Growth	3.58%	-2.04%	5.22%	-14.60%	-2.03%	-0.30%	3.90%	-7.83%	-2.88%	-4.07%
EBITDA Q/Q Growth	-195.61%	134.59%	-499.53%	55.68%	504.40%	-114.53%	64.69%	-15.07%	622.74%	-117.54%
EBIT Q/Q Growth	-362.34%	115.85%	-1,582.65%	734.01%	162.03%	-162.77%	120.18%	-20.03%	230.67%	-167.54%
NOPAT Q/Q Growth	-426.46%	112.95%	-1,957.94%	-134.06%	167.95%	-159.92%	145.87%	-80.58%	554.31%	-134.52%
Net Income Q/Q Growth	-534.90%	107.02%	-22,087.24%	-107.32%	119.71%	-237.42%	136.39%	-80.12%	325.34%	-174.16%
EPS Q/Q Growth	-529.41%	107.14%	-23,700.00%	-107.14%	118.92%	-237.04%	134.78%	-80.00%	325.49%	-176.12%
Operating Cash Flow Q/Q Growth	-17.97%	-38.62%	1,443.31%	-93.87%	6.15%	43.65%	260.90%	-186.49%	-10.25%	-38.91%
Free Cash Flow Firm Q/Q Growth	-2.64%	21.58%	1,599.66%	56.88%	103.23%	-0.93%	-95.92%	-202.89%	-144.58%	47.92%
Invested Capital Q/Q Growth	-9.90%	-0.99%	-14.98%	1.42%	-4.25%	-6.58%	7.92%	4.42%	6.52%	-2.80%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	62.65%	70.08%	69.96%	70.47%	72.12%	58.60%	72.91%	72.25%	71.70%	67.74%
EBITDA Margin	-7.97%	8.63%	-24.44%	6.44%	7.22%	-1.75%	12.00%	7.57%	10.80%	-2.01%
Operating Margin	-11.91%	4.24%	-28.60%	2.11%	3.29%	-5.29%	8.50%	3.34%	5.26%	-3.77%
EBIT Margin	-11.66%	4.60%	-28.45%	2.02%	3.42%	-5.40%	8.57%	4.05%	7.25%	-5.39%
Profit (Net Income) Margin	-8.10%	1.93%	-26.93%	-0.13%	1.49%	-7.41%	5.38%	2.36%	10.95%	-4.72%
Tax Burden Percent	62.46%	62.43%	89.83%	-48.41%	78.07%	107.27%	72.46%	77.98%	234.92%	87.66%
Interest Burden Percent	111.29%	67.17%	105.38%	13.07%	55.87%	127.99%	86.55%	74.90%	64.35%	100.00%
Effective Tax Rate	0.00%	37.57%	0.00%	148.41%	21.93%	0.00%	27.54%	22.02%	-134.92%	0.00%
Return on Invested Capital (ROIC)	-15.68%	4.75%	-35.79%	-1.82%	4.93%	-7.29%	11.76%	5.33%	28.11%	-6.33%
ROIC Less NNEP Spread (ROIC-NNEP)	-15.11%	3.38%	-48.42%	-0.11%	1.76%	-17.29%	9.17%	4.31%	18.08%	-17.32%
Return on Net Nonoperating Assets (RNNOA)	-3.79%	0.99%	-14.72%	-0.03%	0.34%	-3.84%	1.50%	0.53%	1.45%	-1.98%
Return on Equity (ROE)	-19.46%	5.74%	-50.51%	-1.85%	5.27%	-11.13%	13.27%	5.86%	29.56%	-8.32%
Cash Return on Invested Capital (CROIC)	11.96%	11.62%	14.57%	-1.52%	0.72%	-3.19%	-6.22%	2.81%	4.45%	11.36%
Operating Return on Assets (OROA)	-12.32%	4.84%	-30.15%	2.16%	3.71%	-6.08%	9.22%	4.58%	8.65%	-6.85%
Return on Assets (ROA)	-8.56%	2.03%	-28.54%	-0.14%	1.62%	-8.35%	5.79%	2.67%	13.08%	-6.00%
Return on Common Equity (ROCE)	-19.46%	5.74%	-50.51%	-1.85%	5.27%	-11.13%	13.27%	5.86%	29.56%	-8.32%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-14.60%	-21.64%	-0.41%	0.00%	7.12%	7.83%	8.67%	0.00%	4.55%
Net Operating Profit after Tax (NOPAT)	-37	11	-88	-4.27	13	-18	31	13	65	-14
NOPAT Margin	-8.34%	2.65%	-20.02%	-1.02%	2.57%	-3.70%	6.16%	2.60%	12.35%	-2.64%
Net Nonoperating Expense Percent (NNEP)	-0.57%	1.37%	12.63%	-1.72%	3.17%	10.01%	2.60%	1.02%	10.03%	10.98%
Return On Investment Capital (ROIC_SIMPLE)	-3.56%	-	-	-	0.95%	-	-	-	4.96%	-
Cost of Revenue to Revenue	37.35%	29.92%	30.04%	29.53%	27.88%	41.40%	27.09%	27.75%	28.30%	32.26%
SG&A Expenses to Revenue	64.27%	65.85%	64.54%	66.64%	66.79%	63.88%	64.41%	66.88%	62.93%	65.91%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	74.57%	65.85%	98.55%	68.35%	68.84%	63.88%	64.41%	68.92%	66.44%	71.51%
Earnings before Interest and Taxes (EBIT)	-52	20	-125	8.43	17	-27	43	19	38	-29
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-35	37	-107	27	35	-8.72	60	36	56	-11
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.53	0.52	0.76	0.84	1.14	1.24	1.76	2.05	2.13	1.84
Price to Tangible Book Value (P/TBV)	0.69	0.70	1.05	1.42	1.84	2.11	2.85	2.94	3.07	2.74
Price to Revenue (P/Rev)	0.20	0.21	0.28	0.36	0.48	0.51	0.77	0.87	0.86	0.65
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	109.01	17.41	22.51	23.64	18.28	40.50
Dividend Yield	3.48%	7.73%	8.54%	8.93%	8.23%	7.62%	4.90%	4.17%	3.97%	4.98%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.92%	5.74%	4.44%	4.23%	5.47%	2.47%
Enterprise Value to Invested Capital (EV/IC)	0.66	0.62	0.82	0.88	1.14	1.18	1.59	1.88	2.00	1.74
Enterprise Value to Revenue (EV/Rev)	0.31	0.32	0.41	0.49	0.60	0.64	0.90	0.95	0.92	0.70
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	10.72	9.53	9.73	14.25	15.40	11.66	10.74
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	60.68	22.48	21.27	31.74	34.70	19.90	20.10
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	75.10	15.16	18.73	18.30	15.62	34.87
Enterprise Value to Operating Cash Flow (EV/OCF)	4.82	4.01	4.69	6.54	9.88	14.14	27.19	25.54	18.87	8.69
Enterprise Value to Free Cash Flow (EV/FCFF)	4.89	4.89	4.98	0.00	158.02	0.00	0.00	69.53	46.85	14.83
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.60	0.61	0.67	0.60	0.61	0.61	0.57	0.47	0.45	0.50
Long-Term Debt to Equity	0.56	0.53	0.62	0.56	0.58	0.44	0.41	0.42	0.42	0.45
Financial Leverage	0.25	0.29	0.30	0.26	0.19	0.22	0.16	0.12	0.08	0.11
Leverage Ratio	2.22	2.21	2.20	2.09	2.11	2.14	2.07	2.03	2.06	2.10
Compound Leverage Factor	2.48	1.48	2.32	0.27	1.18	2.74	1.79	1.52	1.33	2.10
Debt to Total Capital	37.66%	38.01%	40.05%	37.36%	37.97%	37.95%	36.19%	31.99%	30.96%	33.54%
Short-Term Debt to Total Capital	2.87%	5.26%	2.62%	2.32%	1.89%	10.57%	9.98%	3.62%	1.92%	3.36%
Long-Term Debt to Total Capital	34.79%	32.75%	37.43%	35.04%	36.08%	27.39%	26.21%	28.38%	29.04%	30.18%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	62.34%	61.99%	59.95%	62.64%	62.03%	62.05%	63.81%	68.01%	69.04%	66.46%
Debt to EBITDA	-4.99	-12.89	-5.77	5.50	4.09	3.85	3.95	3.23	2.30	2.73
Net Debt to EBITDA	-2.48	-5.82	-2.84	2.98	1.91	1.93	1.99	1.33	0.71	0.75
Long-Term Debt to EBITDA	-4.61	-11.11	-5.39	5.16	3.88	2.78	2.86	2.86	2.16	2.46
Debt to NOPAT	-3.71	-7.51	-5.15	-46.52	32.23	5.99	5.19	3.84	3.08	8.88
Net Debt to NOPAT	-1.84	-3.39	-2.53	-25.22	15.07	3.01	2.61	1.58	0.95	2.44
Long-Term Debt to NOPAT	-3.43	-6.47	-4.82	-43.64	30.63	4.32	3.76	3.40	2.89	7.99
Altman Z-Score	3.14	3.20	3.05	3.28	3.38	3.35	3.75	4.11	4.29	4.10
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.82	1.93	2.12	2.09	2.13	1.62	1.78	2.08	2.12	2.13
Quick Ratio	0.84	0.90	0.99	0.93	0.99	0.75	0.72	0.82	0.91	0.97
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	179	184	151	-10	4.35	-135	-134	-68	-23	50
Operating Cash Flow to CapEx	204.92%	365.66%	630.40%	27.02%	265.72%	428.58%	241.45%	-192.19%	185.21%	111.73%
Free Cash Flow to Firm to Interest Expense	30.54	28.30	22.52	-1.38	0.59	-17.89	-23.15	-13.95	0.00	0.00
Operating Cash Flow to Interest Expense	4.40	4.84	7.62	0.45	7.35	6.77	6.16	-4.52	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	2.25	3.51	6.41	-1.22	4.59	5.19	3.61	-6.87	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.06	1.05	1.06	1.07	1.09	1.13	1.08	1.13	1.19	1.27
Accounts Receivable Turnover	31.64	24.31	26.58	29.99	37.13	31.98	36.84	37.48	50.21	47.33
Inventory Turnover	2.34	1.93	1.94	1.90	1.95	2.02	1.63	1.61	1.69	1.77
Fixed Asset Turnover	4.26	4.23	4.38	4.43	4.49	4.65	4.68	4.74	4.95	5.30
Accounts Payable Turnover	14.11	12.79	13.93	14.72	12.61	13.82	11.30	13.37	12.14	14.03
Days Sales Outstanding (DSO)	11.54	15.02	13.73	12.17	9.83	11.41	9.91	9.74	7.27	7.71
Days Inventory Outstanding (DIO)	155.96	189.11	188.11	191.64	186.77	181.08	224.54	226.42	215.82	206.34
Days Payable Outstanding (DPO)	25.87	28.54	26.20	24.80	28.96	26.40	32.31	27.30	30.07	26.02
Cash Conversion Cycle (CCC)	141.63	175.59	175.64	179.02	167.64	166.08	202.14	208.86	193.02	188.04
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	813	903	912	1,072	1,029	1,075	1,151	1,066	1,021	959
Invested Capital Turnover	1.88	1.80	1.79	1.78	1.92	1.97	1.91	2.05	2.28	2.40
Increase / (Decrease) in Invested Capital	-216	-173	-239	5.82	8.19	116	164	81	87	-65
Enterprise Value (EV)	538	562	749	942	1,172	1,272	1,833	2,004	2,039	1,669
Market Capitalization	343	366	523	680	937	1,019	1,577	1,830	1,915	1,552
Book Value per Share	$13.10	$14.22	$13.82	$16.36	$16.64	$16.46	$17.94	$18.05	$18.16	$16.71
Tangible Book Value per Share	$9.93	$10.50	$10.02	$9.64	$10.29	$9.68	$11.09	$12.57	$12.63	$11.25
Total Capital	1,045	1,140	1,144	1,293	1,325	1,325	1,403	1,313	1,300	1,267
Total Debt	394	433	458	483	503	503	508	420	402	425
Total Long-Term Debt	364	373	428	453	478	363	368	373	377	382
Net Debt	196	196	225	262	235	253	255	173	124	117
Capital Expenditures (CapEx)	13	8.60	8.12	12	20	12	15	11	14	25
Debt-free, Cash-free Net Working Capital (DFCFNWC)	74	136	143	147	130	157	235	202	147	147
Debt-free Net Working Capital (DFNWC)	272	374	376	368	398	407	488	448	426	455
Net Working Capital (NWC)	242	314	346	338	373	267	348	401	401	412
Net Nonoperating Expense (NNE)	-1.05	3.08	30	-3.74	5.26	18	3.91	1.15	7.29	11
Net Nonoperating Obligations (NNO)	162	196	225	262	207	253	255	173	124	117
Total Depreciation and Amortization (D&A)	16	17	18	18	19	18	17	17	19	18
Debt-free, Cash-free Net Working Capital to Revenue	4.27%	7.67%	7.75%	7.70%	6.61%	7.84%	11.52%	9.59%	6.61%	6.18%
Debt-free Net Working Capital to Revenue	15.70%	21.07%	20.38%	19.32%	20.21%	20.33%	23.88%	21.32%	19.12%	19.14%
Net Working Capital to Revenue	13.97%	17.69%	18.76%	17.74%	18.94%	13.34%	17.02%	19.07%	18.00%	17.35%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.73)	$0.17	($2.38)	($0.01)	$0.14	($0.74)	$0.54	$0.23	$1.16	($0.51)
Adjusted Weighted Average Basic Shares Outstanding	49.66M	49.71M	49.69M	49.54M	49.71M	49.86M	49.93M	49.64M	50.00M	50.20M
Adjusted Diluted Earnings per Share	($0.73)	$0.17	($2.38)	($0.01)	$0.14	($0.74)	$0.54	$0.23	$1.15	($0.51)
Adjusted Weighted Average Diluted Shares Outstanding	49.66M	49.73M	49.69M	49.54M	49.86M	49.86M	50.16M	50.06M	50.53M	50.20M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	49.72M	49.71M	49.70M	49.67M	49.42M	49.41M	49.96M	49.91M	49.46M	49.42M
Normalized Net Operating Profit after Tax (NOPAT)	-5.04	11	17	11	20	-18	31	20	32	6.89
Normalized NOPAT Margin	-1.13%	2.65%	3.79%	2.68%	4.16%	-3.70%	6.16%	4.19%	6.14%	1.28%
Pre Tax Income Margin	-12.97%	3.09%	-29.98%	0.26%	1.91%	-6.91%	7.42%	3.03%	4.66%	-5.39%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-8.86	3.05	-18.59	1.15	2.27	-3.57	7.43	3.98	0.00	0.00
NOPAT to Interest Expense	-6.34	1.75	-13.08	-0.58	1.70	-2.45	5.34	2.56	0.00	0.00
EBIT Less CapEx to Interest Expense	-11.00	1.72	-19.80	-0.53	-0.50	-5.15	4.88	1.63	0.00	0.00
NOPAT Less CapEx to Interest Expense	-8.48	0.43	-14.29	-2.26	-1.06	-4.03	2.79	0.21	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-8.14%	-27.34%	-30.12%	-1,846.98%	903.11%	132.21%	110.14%	99.58%	73.50%	200.68%
Augmented Payout Ratio	-8.14%	-27.34%	-30.12%	-1,846.98%	1,054.49%	171.54%	110.14%	99.58%	140.35%	383.41%

Frequently Asked Questions About Nu Skin Enterprises' Financials

When does Nu Skin Enterprises's fiscal year end?

According to the most recent income statement we have on file, Nu Skin Enterprises' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Nu Skin Enterprises' net income changed over the last 2 years?

Nu Skin Enterprises' net income appears to be on an upward trend, with a most recent value of -$146.59 million in 2024, falling from $104.78 million in 2022. The previous period was $8.60 million in 2023. See Nu Skin Enterprises' forecast for analyst expectations on what’s next for the company.

What is Nu Skin Enterprises's operating income?

Nu Skin Enterprises's total operating income in 2024 was -$151.59 million, based on the following breakdown:

Total Gross Profit: $1.18 billion
Total Operating Expenses: $1.33 billion

How has Nu Skin Enterprises revenue changed over the last 2 years?

Over the last 2 years, Nu Skin Enterprises' total revenue changed from $2.23 billion in 2022 to $1.73 billion in 2024, a change of -22.2%.

How much debt does Nu Skin Enterprises have?

Nu Skin Enterprises' total liabilities were at $817.46 million at the end of 2024, a 17.1% decrease from 2023, and a 11.5% decrease since 2022.

How much cash does Nu Skin Enterprises have?

In the past 2 years, Nu Skin Enterprises' cash and equivalents has ranged from $186.88 million in 2024 to $264.73 million in 2022, and is currently $186.88 million as of their latest financial filing in 2024.

How has Nu Skin Enterprises' book value per share changed over the last 2 years?

Over the last 2 years, Nu Skin Enterprises' book value per share changed from 18.16 in 2022 to 13.10 in 2024, a change of -27.8%.

Related Companies

This page (NYSE:NUS) was last updated on 5/25/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Nu Skin Enterprises (NUS) Financials

Frequently Asked Questions About Nu Skin Enterprises' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Nu Skin Enterprises (NUS) Financials

Annual Income Statements for Nu Skin Enterprises

Quarterly Income Statements for Nu Skin Enterprises

Annual Cash Flow Statements for Nu Skin Enterprises

Quarterly Cash Flow Statements for Nu Skin Enterprises

Annual Balance Sheets for Nu Skin Enterprises

Quarterly Balance Sheets for Nu Skin Enterprises

Annual Metrics And Ratios for Nu Skin Enterprises

Quarterly Metrics And Ratios for Nu Skin Enterprises

Frequently Asked Questions About Nu Skin Enterprises' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools